Revolution Medicines, Inc. (RVMD) Net margin 2018–2023
Revolution Medicines, Inc. (RVMD) net profit margin by fiscal year — reported net income divided by reported revenue.
-3768.3%FY2023 · since FY2018: -207.2% → -3768.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -3768.3% | -3065.3 pp |
| FY2022 | -703.0% | -66.4 pp |
| FY2021 | -636.6% | -384.9 pp |
| FY2020 | -251.6% | -156.4 pp |
| FY2019 | -95.2% | +112.0 pp |
| FY2018 | -207.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net incomeRVMD Gross profitRVMD Gross marginRVMD Operating incomeRVMD Operating marginRVMD Operating cash flowRVMD Free cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Total liabilitiesRVMD Shareholders’ equityRVMD overview →